FDAInternational Bladder Cancer GroupNCTFDA-approved
…n launched and their outcomes are awaited. As of June 2025, the FDA has approved valrubicin, pembrolizumab, nadofaragene firadenove…
32articles mentioning institutions
107institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: FDA ×
FDA
This institution is selected. Its supporting articles are shown below.
Articles mentioning FDA
32 articles · page 1 of 3FDAFDAVeterans Health AdministrationSELECT trialObesitytirzepatide
…edications regarding impurities and adverse effects.224–228 The FDA considers the use of compounded obesity medications as risky, a…
Yale UniversityHarvard Pilgrim Health Care InstitutePeking UniversityLondon School of Economics and Political ScienceUniversity of YorkFDA
…alth Care Institute, University of York, Peking University, and Yale University. Typical mediums include press releases, social media posts (X,…
FDAMayo Clinic Cancer RegistryReferencesstage IIB/C melanomaPembrolizumabstage IIB/IIC melanomaadjuvant immunotherapy
…B/IIC patients were identified from 2018-2022 in NCDB. Prior to FDA approval, 366/5989(6.1%) with stage IIB and 269/3363(8.0%) with…
FDANational Institute for Health and Care Research Innovation ObservatoryEMATGAMHRANICENational Institute for Health and Care Excellence
…r of medicines approved by the following regulatory agencies is FDA (n=84, 55%), EMA (n=80, 52%), MHRA (n=71, 46%), TGA (n=51, 33%)…
FDANCT05896371European Association of Nuclear MedicineEANMprostate cancerMerkel cell carcinomanivolumabsmall cell lung cancer177Lu-PSMA
… trials (2021–2025). ARPI, Androgen receptor pathway inhibitor; FDA, Food and Drug Administration; mCRPC, metastatic Castration Res…
FDAAsociación Latinoamericana para el Estudio del HígadoEuropean Association for the Study of the LiverEuropean Medicines AgencyAmerican Association for the Study of Liver Diseases
…hase 3 trials are expected in 2029-32 and will inform potential FDA approval.Triple incretin receptor agonists In a phase 2 clinica…
FDA
…ntly in the last stages of review for DDT qualification through FDA’s ISTAND program.…
Memorial Sloan Kettering Cancer CenterUniversity of Western OntarioAmerican Society for Radiation OncologyAmerican Society of Clinical OncologyRadiation Therapy Oncology GroupMontrealASTROAJCCASCO
…line in composite MDADI scores after treatment at 2 years.58 At Memorial Sloan Kettering Cancer Center, a cohort of 276 HPV-positive OPC patients (including 31.5% AJC…
FDAFDAWHOCochrane Central LibraryPubMedEmbaserheumatoid arthritissystemic sclerosisWHORA+1 more
…2 were conducted on SSc, 4 studies investigated both diseases. ‘FDA MACE’ definition was employed in 46 papers on RA (13%) and 2 pa…